Skip to content

VERBEKEN EYECARE

Active
Private limited companyfounded 2024active for 1 yearRue de Lessines 52, 7890 Ellezelles, BelgiumKBO/BCE: BE 1017.153.282
Summary

VERBEKEN EYECARE has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €102,895 and a net result of €97,895. Its solvency ranks better than 23% of 20,358 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
2 sites
Size
€404,803total assets 2025
Staff
1 FTE
Equity
€102,895
Profit
€97,895
Turnover not published (micro format)
Financial health
92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 39 days early0 of 1 deed read
Why 92lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.59, cash €159,542Size: total assets €404,803Figures for financial year 2025 (filed 22-06-2026)Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 39% of its sector peers (NACE 86, micro)
Financial strength
Strong
Solvency 50
equity 25.4% of total assets
Liquidity 59
short-term debt 74.6% · cash 39.4%
Profitability 99
return on assets 24.2%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,058 companies, NACE 86, micro)
Last 24 months 01-2026: 0.3% 02-2026: 0.4%▲ +0.1 percentage points vs 01-2026 03-2026: 0.4%● unchanged vs 02-2026 04-2026: 0.4%● unchanged vs 03-2026 05-2026: 0.4%● unchanged vs 04-2026 06-2026: 0.4%● unchanged vs 05-2026 07-2026: 0.4%● unchanged vs 06-2026 08-2026: 0.5%▲ +0.1 percentage points vs 07-2026highest value 09-2026: 0.4%▼ -0.1 percentage points vs 08-2026 10-2026: < 0.1%▼ -0.4 percentage points vs 09-2026lowest value
Credit of up to €9,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity insufficient (current ratio 0.59, below 1; short-term debt: 74.6% and cash: 39.4% of total assets), and 74.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 23% on solvency, 36% on liquidity and 59% on profitability.

The bankruptcy probability was computed on 15-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 0.59, cash €159,542
NBB · annual accounts
lowers risk · Size: total assets €404,803
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 22-06-2026)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 20358 sector peers (2025).
NBB · sector comparison
Position among 20358 sector peers
Solvency
better than 23%
← weakest strongest →
raises risk · Young company
Founded in 2024, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-06-2026, 39 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
39 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…

Key points

  • Total assets 2025first financial year filed €404,803 View
  • Active since 2024founded 10-12-2024 1 years View

By topic

Financials

Financial year
2025
Total assets
€404,803
Profit
€97,895
Solvency
25.4%
Go to Financials

Company details

Sites
2
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
10-12-2024
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.